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Abstract
Background: A granulomatous inflammatory response develops in jirds infected subcutaneously
or intraperitoneally with filarial nematodes namely Brugia pahangi and B. malayi. Previous studies by
light and electron microscopy have shown cellular inflammatory responses in and around these
granulomas. Furthermore, the cellular inflammatory responses of granulomas found in the
lymphatics and peritoneal cavity appear to be similar. The purpose of this study was to determine
the cytokine profiles of granulomas in the peritoneal cavity of B. pahangi-infected jirds and to
determine whether the granulomas release any proinflammatory cytokines ex vivo.
Methods: A semiautomated quantitative polymerase chain reaction (Q-PCR) was performed on
cDNA prepared from the granulomas of infected jirds to study the species-specific mRNA
expression of IL-2, IL-4, IFN-γ, IL-5, and IL-10. Genomic DNA was extracted from the granulomas,
and parasite DNA was detected by Q-PCR by amplifying the HhaI repeat sequence. The levels of
the inflammation-causing cytokines IL-6 and TNFα that were secreted by the granulomas were
measured by cell-based assays.
Results: Florid granulomas showed higher levels of IFN-γ than other cytokines, linking this Th1
cytokine to the granulomatous inflammation that develops in jirds and humans. IL-4 expression was
much lower than that of IFN-γ but higher than that of IL-10. A low level of IL-5 mRNA expression
was detectable in all granulomas as was the level of IL-2 expression. The levels of the inflammatory
cytokines IL-6 and TNFα, secreted by intact granulomas, spontaneously increased by 48 h after
culture. Parasite antigen stimulation and subsequent release of IL-6 and TNFα by the granulomas
indicated a moderate increase in the levels of these two cytokines. The amplification of the Brugia
HhaI repeat DNA and Wolbachia  16S rDNA indicated worm components and bacterial
components in the granulomatous tissue.
Conclusion: Granuloma development in filarial infections is a complex process involving cellular
reactions responding to parasite/bacteria and their components. The interactions between worm-
derived granulomas and their hosts are dynamic and multifaceted. The data collected thus far
suggest that the expression profiles of many of the measured cytokines in the lymphoid tissues of
Brugia-infected jirds are different from those of the cytokines in granulomas. Moreover, granulomas
have the ability to secrete the inflammatory cytokines IL-6 and TNFα.
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Background
Lymphatic filariasis, caused by the filarial nematodes
Wuchereria bancrofti,  Brugia malayi, and Brugia timori,
affects more than 120 million people worldwide. The
most common clinical signs of infection are recurrent epi-
sodes of filarial fever coupled with inflammation of the
affected lymphatics [1-4]; in most cases, these symptoms
are accompanied by the appearance of microfilariae in the
peripheral blood [3,5,6]. In lymphatic filariasis, the path-
ological lesions are found in the lymphatics as a result of
their dysfunction and the attendant injury to the walls and
valves [7-10]. The lesions are generally granulomas with
deposits of collagenous material. In humans, granuloma-
tous lesions around nodules with a filarial aetiology have
been observed [11,12]. In endemic areas, lumps in the
affected breasts and testicles and a coin-like shadow in the
lungs have been attributed to granulomatous reactions to
filarial worms. Similarly, lymphatic lesions in animals
infected with filarids are primarily granulomatous [13-
18]. The origin of granulomatous inflammation in lym-
phatics is commonly associated with the host's response
to dead or dying worms and to their somatic excretions
and secretions. Interestingly, it has been shown that the
granulomatous lesions resulting from mycobacteria and
schistosoma are mediated by T cells [19,20].
Among rodents, jirds are highly permissive for filarial
infections, including Brugia spp., Litomosoides sigmodontis,
and  Acanthocheilonema viteae. Previous studies have
shown that a granulomatous inflammatory response
develops in Brugia-infected jirds and consists of different
types of granulomatous lesions involving several cell
types. However, the lesions in the lymphatics and the peri-
toneal cavity are similar [21,22].
We have observed that the Mongolian jird-Brugia experi-
mental model reflects, in many ways, the status of
humans infected with B. malayi or W. bancrofti [23,24]. In
particular, initially, infection with the filarial nematode
Brugia in jirds produces a cellular hyperresponsiveness to
worm antigen around 28 days after infection (DAI), and
the number of lymph thrombi (LT) is increased after 56–
90 DAI. During this period of infection, jirds also show an
increase in the number and size of LT and an increased
pulmonary granulomatous (PGRN) response to Brugia
antigen-coated sepharose beads embedded in their lungs
[23,24]. After approximately 90 DAI, the time at which
microfilaremias are well established in the circulation, the
cellular response to filarial antigens decrease, as do the
numbers and sizes of LT and PGRN inflammation
[23,24]. In contrast, the LT that are formed in the lym-
phatics during the onset of a Brugia infection remain unre-
solved during the entire course of infection. The results
from these studies suggest that multiple mechanisms are
involved in the cell-mediated formation of PGRN and LT.
However, much remains unknown about the specific reac-
tions associated with the development of filarial granulo-
mas in infected tissues and about granuloma-associated
pathology in humans and animals.
Recently, many jird cytokine genes were characterized and
highly sensitive and specific quantitative polymerase
chain reaction (Q-PCR) methods were developed to study
the cytokine expression in lymphoid and nonlymphoid
tissues [25,26]. This paper reports on the major T-cell
cytokine gene-expression profiles in granulomas in the
peritoneal cavity of jirds following a primary infection
induced by infective third-stage larvae (L3). Using the
polymerase chain reaction, we found that these granulo-
mas originated from parasites/bacteria and were responsi-
ble for the localized cellular inflammatory responses
involving cytokines.
Methods
Animals and infections
Mongolian jirds (Meriones unguiculatus) were obtained
from Charles River (Wilmington, MA) at 8 weeks of age.
They were fed standard rodent chow and given water ad
libitum.  B. pahangi infective L3 were recovered from
infected Aedes aegypti mosquitoes using Baermannization,
as previously described [23], and randomly divided into
aliquot doses of 100 larvae in 0.5 ml of RPMI (GIBCO/
Invitrogen Corp., Carlsbad, CA). Jirds were injected intra-
peritoneally (i.p.) with 300 B. pahangi L3, and 300 DAI,
necropsies were performed on six jirds infected i.p. to
recover florid granulomas.
Worm antigen
To prepare a soluble extract of worm antigen, adult worms
were aseptically obtained from the peritoneal cavities of
infected jirds and placed in phosphate-buffered saline
(pH 7.2), as described previously [23]. The protein con-
tent in the adult worm extract was estimated by a Bradford
assay [23] and aliquots of this soluble extract were stored
at -70°C until used.
Granulomas
Figure 1A and 1B shows adherent granulomatous lesions
within the lymphatics of jirds infected subcutaneously
with B. pahangi. In majority of animals, worms were visi-
ble within the lymphatics (Fig. 1C). Since the nonadher-
ent florid granulomas (Fig. 1D) in the peritoneal cavity of
chronically infected jirds are much larger (~5–10 mm)
than the adherent ones, we selected these for study. All
florid granulomas (Fig. 1D) were surgically removed from
the peritoneal cavity of six infected jirds and washed three
times with RPMI-1640 containing 100 U/ml penicillin,
100 µg/ml streptomycin, and 0.5 µg/ml gentamicin. Six
granulomas were randomly selected from six jirds, and
each granuloma was aseptically cut in half. One half of theFilaria Journal 2006, 5:3 http://www.filariajournal.com/content/5/1/3
Page 3 of 9
(page number not for citation purposes)
granuloma was used for total RNA preparation, and the
other half was used for genomic DNA extraction. Addi-
tional granulomas (n = 3) from these infected jirds were
pooled and placed in cultures to study their secretion of
IL-6 and TNFα cytokines ex vivo.
Quantitation of cytokine mRNA
Extracts of granulomas were prepared in phosphate-buff-
ered saline (n = 6, one half from each granuloma) by
grinding the tissue to near homogeneity with a tabletop
tissue grinder and then centrifuging for 10 min at 1000
rpm. The extract samples were resuspended in 0.5 ml of
RNAStat 60 (Tel-test, Friendship, TX) and then snap fro-
zen on dry ice. Total RNA was isolated from the sample by
using chloroform extraction in accordance with the man-
ufacturer's instructions. The quality and quantity of RNA
was determined by a spectrophotometer (Beckman Coul-
ter Inc., Fullerton, CA). Reverse transcription was carried
out on 1 µg RNA, as previously described [27,28].
The jird T-cell cytokines interleukin (IL)-2 (Genbank
accession no. X68779), IL-4 (L37779), IL-5 (L37780), IL-
10 (L37781), interferon-γ (IFN-γ) (L37782), and the
hypoxanthine phosphoribosyltransferase (HPRT)
(L37778) were quantitated in all granuloma cDNA sam-
ples using the Q-PCR system 5000 (Applied Biosystems,
Pathological lesions in jirds infected with Brugia pahangi Figure 1
Pathological lesions in jirds infected with Brugia pahangi. A, Gross pathology of spermatic cord lymphatic vessel of a subcutane-
ously infected jird with B. pahangi (56 DAI) shows white granulomas (arrows) embedded in the vessel lumen (magnification 3×). 
B, Lymphatic vessel shows rounded and attached granulomas (arrows) (higher magnification, 7×). C, The same spermatic cord 
lymphatic vessel at the posterior end also contains a worm (arrows) tucked in the vessel lumen (lymphatic vessel was dyed 
with Evan's blue for contrast is adjacent to a blood vessel (BV) and embedded in fat tissue (FT), magnification 3×. D, Large non-
adherent, florid granulomas from the peritoneal cavity of B. pahangi-infected jirds recovered at the chronic stage (300 DAI), 
magnification 3×.Filaria Journal 2006, 5:3 http://www.filariajournal.com/content/5/1/3
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Foster City, CA). Gene-specific oligonucleotide primers
and probes were generated commercially (GeneLab,
Baton Rouge, LA; Baron Biotech, Milford, CT). Positive
strand primers were biotinylated on their 5' terminus. All
probes were labeled with a chemiluminescent tris {2,2'-
bipyridine} ruthenium (II) chelate (TBR; Baron Biotech)
on their 5' terminus. Labeled primers and probes were
purified by high-performance liquid chromatography to
eliminate unlabeled oligonucleotides.
All PCR analyses were carried out in duplicate in 50-µl
reactions, and PCR cycling conditions were as described
before [27,28]. All values were normalized against those
of the housekeeping gene, HPRT, as previously described
[25]. Data are presented for each cytokine as the normal-
ized luminosity unit ± standard error.
Extraction and detection of parasite DNA
Total genomic DNA was extracted from B. pahangi adult
worms (n = 5) and from the second halves of the 6 gran-
ulomas by using reagents supplied in the DNAeasy kit
(Qiagen, Valencia, CA). Extracted genomic DNA was ana-
lysed for purity using a Beckman spectrophotometer and
stored at -20°C until used. Parasite DNA detection was
performed in genomic DNA preparations of granulomas
by using the Q-PCR system 5000 (Applied Biosystems).
For this purpose, HhaI repeat DNA sequence was ampli-
fied in a Q-PCR machine as described before [27]. The
mean luminosity units obtained by the HhaI PCR assay
served as a positive signal for detecting parasite DNA.
Adult worm genomic DNA (1 ng) was used as a positive
control sample for detecting parasite DNA (HhaI repeat
sequence) in a Q-PCR assay. Water was used as a negative
control in a PCR. For the detection of Wolbachia  16S
rDNA, sequence specific primers were employed and the
PCR products were analysed by gel electrophoresis [29].
Quantitation of interleukin and tumor necrosis factor
The secretion of interleukin-6 (IL-6) and TNFα from gran-
ulomas was measured by bioassays. For this purpose, 3
granulomas from 3 infected jirds were placed in one ml of
complete medium (RPMI-1640 containing 100 U/ml
penicillin, 100 µg/ml streptomycin, 1% amphotericin-B
solution, and 5% fetal calf serum). The granulomas were
cultured with or without 10 µg/ml B. pahangi adult worm
soluble extract in complete medium at 37°C in 5% CO2
and 95% air. All culture supernatants (~200 µl) were col-
lected from each sample at 6, 24, and 48 h; centrifuged for
10 min at 1000 RPM; and supernatants were stored at -
20°C until used.
The concentrations of secreted IL-6 were determined using
the well-established B9 bioassay [30,31]. In this assay, the
proliferation rate of IL-6-dependent murine B9 hybrid-
oma cells is determined after the cells are incubated with
supernatants from granuloma cultures. Because the B9
bioassay is highly sensitive, IL-6 concentrations as low as
10 pg/ml were detected. Briefly, to assay IL-6 activity,
supernatants from the granuloma cultures were thawed,
vortexed, and added in duplicate to 96-well plates in 100-
µl amounts. In parallel, equal volumes of supernatants
from Con-A-stimulated jird lymph node cells [24] in
duplicate were plated into 96-well plates as positive con-
trols. An equal amount of culture medium in duplicate
was included as a negative control. Thoroughly washed B9
cells were resuspended in complete medium and added to
each well at a density of 2.5× 103 cells/well, and the plates
were incubated at 37°C for 6, 24, and 48 h. After the cells
were incubated, they were pulsed with [3H]thymidine
(DuPont NEN Research Products, Boston, MA) for 24 h.
The cells were harvested on glass-fibre filter mats with a
cell harvester (TOMTEC, Hamden, CT) and counted in a
Betaplate liquid scintillation counter (LKB-1205, Gaith-
ersburg, MD). Results were expressed as net counts per
minute [24].
To assay TNFα concentrations, granuloma culture super-
natants in parallel with human-TNFα standards were
plated into 96-well plates [32,33]. WEHI-164 murine fib-
rosarcoma cell line-clone 13 (American Type Culture Col-
lection, Manassas, VA) was selected to test for TNFα
cytotoxicity. Cells from stock cultures with RPMI-1640
containing a mixture of 100 U/ml penicillin, 100 µg/ml
streptomycin, and 1% amphotericin-B solution were thor-
oughly washed and resuspended in complete medium
containing 2 µg/ml actinomycin-D (Sigma Chemical co.,
St. Louis, MO). These cells were added to each well at a
density of 2 × 104 cells/well, and the plates were incubated
at 37°C for 6, 24, and 48 h with or without supernatants
from granuloma cultures. Human TNFα (R & D Systems,
Minneapolis, MN) in 5-fold dilutions at final concentra-
tions of 0.002-7.39 U/ml was added in duplicate to wells
containing cells. These cultures served as positive controls
to generate values for a standard curve. Supernatants from
the Con-A-stimulated jird lymph-node cells [24] and cul-
ture medium were also used in this assay as positive and
negative controls, respectively. The cytotoxic effect of
TNFα on WEHI cells cultured with or without granuloma
supernatants and positive and negative controls was
measured by assessing the cell viability in a methylthiazo-
letetrazolium (MTT) assay [34]. Subsequently, a standard
curve of absorbance versus the TNFα concentration was
plotted, and TNFα bioactivity in the supernatants was
interpolated from the standard curve and expressed in U/
ml. The minimum sensitivity of this assay to TNFα by this
assay was 0.002 U/ml.
Statistics
Analysis of variance (ANOVA) was carried out to deter-
mine whether the granulomas showed significantly differ-Filaria Journal 2006, 5:3 http://www.filariajournal.com/content/5/1/3
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ent cytokine mRNA profiles. The differences were
considered statistically significant at p < 0.05.
Results
Analysis of cytokine mRNA as determined by net lumi-
nosity units showed differences in the T-cell cytokine pro-
file in granulomas induced by B. pahangi infections in
jirds. In particular, the expression levels of IFN-γ mRNA
were significantly (p < 0.05) higher than those of other
cytokines in all granulomas from chronically infected
jirds (Fig. 2). In addition, the expression of IL-4 mRNA
was lower than that of IFN-γ mRNA but significantly
higher than that of other cytokines (p < 0.05). The expres-
sion of IL-10 mRNA was lower than that of IL-4 mRNA
but was significantly higher than that of IL-2 and IL-5
mRNA (p < 0.05). The expression levels of both IL-5 and
IL-2 mRNA were significantly lower than those of all the
other cytokines (p < 0.05) (Fig. 2). In summary, the gran-
ulomas contained detectable levels of the Th2 cytokines
(IL-4, IL-5, IL-10, and IL-2), but the expression pattern of
the Th1-type cytokine IFN-γ differed in the granulomas
(Fig. 2).
The granulomas spontaneously produced the pro-inflam-
matory cytokines IL-6 and TNF in culture (Figs. 3 &4), and
under these culture conditions, the levels of these
cytokines progressively increased between 6 and 48 h.
From the IL-6-dependent B9 cell culture assay, we found
that granuloma supernatants released IL-6 in-vitro and the
results were comparable to those in cultures supple-
mented with supernatants from Con-A stimulated cells
(Fig. 3). The counts per minute used to judge the stimula-
tion of B9 cell growth indicated an increase in the granu-
loma secretion of IL-6 over time, but the results are
statistically insignificant. Upon stimulation with adult
worm antigen, granulomas released moderately high lev-
Levels of pro-inflammatory cytokine TNFα released by gran- ulomas Figure 4
Levels of pro-inflammatory cytokine TNFα released by gran-
ulomas. Granulomas were cultured in vitro for 6, 24, and 48 h 
with or without B. pahangi worm antigen and secreted TNFα 
levels were measured in the supernatants using a WEHI-cell 
culture assay. Results are expressed as U/ml. Supernatants 
from jird lymph node cells stimulated with Con-A and cul-
ture medium served as positive and negative controls.
Cytokine mRNA levels in the granulomas of B.pahangi- infected jirds Figure 2
Cytokine mRNA levels in the granulomas of B. pahangi-
infected jirds. Granulomas were obtained from the perito-
neal cavity and their cytokine as well as HPRT mRNA 
expression levels were measured using Q-PCR. Cytokine 
mRNA levels are expressed as mean luminosity units ± 
standard error after normalizing their values with HPRT val-
ues. IL, interleukin; IFN-γ, interferon gamma.
Levels of pro-inflammatory cytokine IL-6 released by granu- lomas Figure 3
Levels of pro-inflammatory cytokine IL-6 released by granu-
lomas. Granulomas were cultured in vitro for 6, 24, and 48 h 
with or without B. pahangi worm antigen. Cytokine levels 
were then measured in the supernatants of granuloma cul-
tures using a B9-cell culture assay for IL-6. Results are 
expressed as counts per minute of [3H]thymidine incorpo-
rated, indicating the effect of granuloma-culture supernatants 
containing IL-6 on B9 cell growth. Supernatants from jird 
lymph node cells stimulated with Con-A and culture medium 
served as positive and negative controls.Filaria Journal 2006, 5:3 http://www.filariajournal.com/content/5/1/3
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els of IL-6. The increase in IL-6 over time upon antigen
stimulation is statistically significant (p < 0.05). In paral-
lel, the relative TNFα levels were significantly increased
between 6 and 48 h (unstimulated cultures: 69% increase,
p ≤ 0.05; antigen-stimulated cultures: 52% increase, p ≤
0.05). However, no statistically significant difference was
observed in TNFα levels between these two types (with
and without antigen stimulation) of cultures (Fig. 4).
The normalized (with the background) luminosity units
of Q-PCR showed the presence of parasite DNA in all
granulomas. Q-PCR detected amplified HhaI DNA in all
granulomas, and the units obtained were similar to those
from adult worm genomic DNA (positive control). This
confirms the presence of parasite DNA in the genomic
DNA extracts of the granulomas (Fig. 5). However, the rel-
ative luminosity units of the amplified HhaI DNA within
the granulomas varied, indicating that they may have dif-
ferent levels of parasites. PCR and gel electrophoresis
results also showed positive signals for Wolbachia DNA in
granulomas.
Discussion
In our study, the Th1-type cytokine was dominant in peri-
toneal granulomas. Interestingly, Th1 cytokines, such as
IFN-γ, are associated with inflammatory processes such as
the granulomatous lesions caused by bacteria and
helminthes. Similarly, our results suggest that IFN-γ plays
a role in the formation of LT in subcutaneously infected
jirds and in the formation of peritoneal granulomas. In
subcutaneously infected jirds, IFN-γ mRNA (Th1 type) has
been induced in lymphoid tissues, but in significantly
lower amounts than IL-4 mRNA (Th2 type) [25,28]. In the
peritoneal exudate cells of the animals whose cell popula-
tions were enriched with macrophages and eosinophils, a
moderate increase in the levels of IFN-γ by 56 DAI was evi-
dent [25]. Furthermore, an increase in IFN-γ expression
was also observed in spermatic cord lymphatics contain-
ing LT, but the increase was much lower than that of the
other Th2-type cytokines [35]. In contrast, we also
observed in the peritoneal exudate cells from jirds with
i.p. infections that the IFN-γ levels were lower than those
of IL-4 and IL-5 [25,26]. When jirds were infected with
Brucella (a known IFN-γ inducer) and then with B. pahangi
(i.p) L3, there was no increase in PGRN response to worm
antigen, although Brucella induced high levels of IFN-γ
[25]. This suggests that, although the kinetics of LT forma-
tion in lymphatics, granuloma formation in the perito-
neal cavity, and PGRN responses in jirds are similar, the
immunological modulators involved in the lymphoid
and nonlymphoid tissues differ. It is also possible that
IFN-γ plays a key role in the induction of one or all these
multiple responses, but it is unlikely that IFN-γ is the only
cytokine contributing to the formation of granulomatous
lesions; it may simply have a small role in the complex
interaction of Th1 molecules with those of Th2 type.
Filariae in general are thought to develop a polarized Th2-
type host immune response and have a severely impaired
ability to produce Th1-type cytokines in humans and
rodents. The development of the hyporesponsive chronic
disease state in humans appears to be complex, involving
Th1 and Th2 cytokines and other mechanisms of innate
immunity [36-39]. Moreover, it has been shown that
immune effector mechanisms involved in hyporesponsive
microfilaremic states also involve an antagonistic Th3/
Th1-type response [40].
Previous studies indicated that the renal lymph node (the
lymphoid tissue draining the infected lymphatics) has the
highest levels of IL-10 mRNA during the chronic phase of
infection [25,35]. However, proportional increases in IL-
10 similar to those seen in the spleen and peritoneal exu-
date cells were not observed in granulomas. Similar stud-
ies conducted in jirds infected i.p. with B. pahangi also
failed to show a distinct role for IL-10 in the down-regula-
tion of the PGRN response. It is possible that IL-10 acts at
the site of infection to down-regulate LT formation, and it
is unlikely that granuloma formation in the peritoneal
cavity is mediated by IL-10 in infected jirds. The expres-
sion profile of cytokines indicate that peritoneal exudate
cells [25] may assist in forming the granulomas further
supports this hypothesis.
IL-5 mRNA expression is transitory in the Brugia-jird
model. The peak in peripheral eosinophilia at 14–28 DAI
reflects the peak of IL-5 mRNA expression observed in the
Detection of parasite DNA in granulomas by HhaI PCR assay Figure 5
Detection of parasite DNA in granulomas by HhaI PCR 
assay. Amplified HhaI repeat DNA was measured in granulo-
mas and expressed as mean luminosity units ± SD. Genomic 
DNA sample of B. pahangi adult worms served as positive 
control sample in HhaI repeat PCR assay by Q-PCR. Water 
was used as a negative control.Filaria Journal 2006, 5:3 http://www.filariajournal.com/content/5/1/3
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lymphoid tissues of infected jirds [25,28,41]. In subcuta-
neously infected jirds, this eosinophilia peaks at approxi-
mately 28 DAI, and IL-5 mRNA levels increase between 14
and 28 DAI, indicating a role for the systemic IL-5
response in infected animals. Levels of IL-5 mRNA were
low in all tissues in chronically infected jirds. We observed
that the levels of IL-5 tend to be low in worm granulomas.
Eosinophilic granulomas in Wuchereria  infections were
observed earlier [42]. In mice and jirds, granulomas con-
tained eosinophils close to the worms, but their numbers
were significantly lower than in macrophages and giant
cells [18,22], suggesting that IL-5 does not play a signifi-
cant role in the development of granulomas at the chronic
stage, unlike it does in these other cell types involved in
phagocytosis. In addition, the profile of IL-5 mRNA
expression, which differs from that of IFN-γ, suggests that
these two cytokines play different roles in the formation
of granulomas. Moreover, IL-5 was found to play a major
role in the recruitment of neutrophils to the site of L. sig-
modontis infections in BALB/cByJ mice and in the develop-
ment of nodules [43] in which macrophages and
eosinophils were the predominant cell types. More
recently, a synergism between the Th1 (IFN-γ) and Th2
(IL-5) cytokines has been observed in murine filariasis,
leading to the containment of infections [44]. The expres-
sion profiles of these cytokines in human filarial granulo-
mas remain to be determined. Interestingly, in human
mycobacterial infections, it has become evident that bac-
teria and host T cells collaborate in granuloma formation,
and some nonspecific T-cell subsets play a role in granu-
loma formation [19,20]. It is unclear whether this is the
case in filarial granulomas.
The spontaneous release of the inflammatory cytokines
IL-6 and TNFα strongly supports their role in inducing
inflammation in the peritoneal cavity and possibly in
lymphatics. It is likely that, in the peritoneal cavity, these
cytokines are responsible for recruiting inflammatory cells
and other mediators causing tissue necrosis and the depo-
sition of collagenous material around tissues of parasite
origin.
On the basis of the morphology and development of gran-
ulomas and nodules, it has been speculated that filarial
granuloma development reflects an innate immune
mechanism by which incoming larvae, developing larvae,
microfilariae, and adult worms are eliminated [18,43,45].
It is possible that filaria infected hosts (for example,
rodents and humans) clear the active infections, such as
granulomas in mycobacterial infections and schisto-
somiasis, by developing granulomas [18,46,47]. If granu-
loma development is a means of containing the live or
dead parasite, leading to its elimination from the body,
then understanding how cytokines and chemokines are
involved in this process might give us clues in the search
for suitable therapeutics to contain worm development
and the subsequent granulomatous inflammation associ-
ated with filarial infections.
Interestingly, a reexamination of transmission electron
microscopy photomicrographs of granulomas [22]
revealed intact and degenerating worm fragments con-
taining  Wolbachia  (data not shown). PCR assays using
genomic DNA and Wolbachia  specific primers for 16S
rDNA confirmed the presence of bacterial components in
these granulomas [29]. Therefore, it is likely that inflam-
matory responses leading to granuloma development are
complex and might be triggered by parasite proteins or
bacterial components, or both. Additional studies are
needed to understand the interaction of Wolbachia in the
granuloma formation.
Although the jird-B. pahangi model of human lymphatic
filariasis has been useful for understanding the immuno-
logical events associated with active infections, there has
been no new information about the roles of individual
immune effector molecules in granuloma development as
the infection progresses. We recently investigated the
expression of various classic Th1 and Th2 cytokines fol-
lowing L3 infections of Brugia in the jird model [28,35].
The results strongly suggest that much of the cellular
response of the granulomas developed in the peritoneal
cavity is immune mediated, differs from the cytokine
expression in lymphoid tissues, and also reflects what
happens in infected lymphatics. A more detailed study of
cytokine profiles in lymphatic granulomas developed
soon after infection, at the acute stage, and at the chronic
stage would further define the role of granulomas in the
pathogenesis of lymphatic filariasis.
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